Pharma-Bio Serv (PBSV) Cash from Investing Activities Growth (3y) (2013 - 2026)
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | -524.66% |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 147.17% |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 10.99% |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | -45.77% |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | -179.30% |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 206.79% |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 45.89% |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | -69.21% |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 79.71% |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -38.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -38.66% |
| Jan 31, 2026 | 32.71% |
| Oct 31, 2025 | -313.27% |
| Jul 31, 2025 | 821.48% |
| Apr 30, 2025 | -804.48% |
| Jan 31, 2025 | 1,031.05% |
| Oct 31, 2024 | 479.59% |
| Jul 31, 2024 | 704.65% |
| Apr 30, 2024 | -117.34% |
| Jan 31, 2024 | -79.86% |
| Oct 31, 2023 | 951.07% |
| Jul 31, 2023 | -1,034.27% |
| Apr 30, 2023 | 469.10% |
| Jan 31, 2023 | -798.08% |
| Oct 31, 2022 | -26.20% |
| Jul 31, 2022 | 39.45% |
| Apr 30, 2022 | -26.15% |
| Jan 31, 2022 | -26.34% |
| Oct 31, 2021 | 26.31% |
| Apr 30, 2021 | 117.93% |